Health and Fitness Health and Fitness
Thu, December 8, 2016
Wed, November 23, 2016
Mon, November 14, 2016
Sun, November 13, 2016
Wed, November 9, 2016
Thu, November 3, 2016
Wed, November 2, 2016
Mon, October 17, 2016
Sat, October 8, 2016
Thu, October 6, 2016
Wed, October 5, 2016
Mon, October 3, 2016
Fri, September 30, 2016
Thu, September 29, 2016
Tue, September 27, 2016
Mon, September 26, 2016
Fri, September 23, 2016
Thu, September 22, 2016
Wed, September 21, 2016
[ Wed, Sep 21st 2016 ] - Market Wire
Last Patient Out
Tue, September 20, 2016
Mon, September 19, 2016
Sun, September 18, 2016
Fri, September 16, 2016
Thu, September 15, 2016
Wed, September 14, 2016
Mon, September 12, 2016
Fri, September 9, 2016
Thu, May 9, 2013
[ Thu, May 09th 2013 ] - Market Wire
Achieves Record Revenues
Wed, May 8, 2013
Tue, May 7, 2013
Mon, May 6, 2013
Sun, May 5, 2013
Fri, May 3, 2013
Thu, May 2, 2013
Wed, May 1, 2013
Tue, April 30, 2013
Mon, April 29, 2013
Sun, April 28, 2013
Fri, April 26, 2013
Thu, April 25, 2013
Wed, April 24, 2013
Tue, April 23, 2013
Mon, April 22, 2013

LED Medical Diagnostics Announces Delay in Reporting Audited Year-End Results




May 01, 2013 19:38 ET

LED Medical Diagnostics Announces Delay in Reporting Audited Year-End Results

BURNABY, BRITISH COLUMBIA--(Marketwired - May 1, 2013) - LED Medical Diagnostics Inc. (TSX VENTURE:LMD)(OTCQX:LEDIF)(FRANKFURT:LME) ("LED" or the "Company") today announced that it will not be in a position to file its audited financial statements, management's discussions and analysis and related certifications for the fiscal year ended December 31, 2012, on or before April 30, 2013, as required, due to the determination in consultation with its new auditor that LED must revise its previously reported financial statement information. The restatement is due to a change in the Company's functional and reporting currency to United States dollars from Canadian dollars and a revision to LED's prior revenue recognition policy pertaining to the sales of its product in fiscal 2011 and 2012 to its then exclusive distributor, Henry Schein Inc., from "sell to the distributor" to "sell through this distributor to their end customers". The revision to LED's revenue recognition policy was brought to the Company's attention in April 2013 and LED has since been reviewing and discussing this issue with its new auditor and its former auditor. The change in functional and reporting currency and revision in revenue recognition policy have created a significant amount of additional work to be performed by LED to complete the audited statements. LED has been working closely with its auditor and expects to be able to have the audit of the financial statements completed, and the statements filed, by May 3, 2013.

LED confirms that it intends to satisfy the alternative information guidelines of Section 4.4 of National Policy 12-203 including the issuance of biweekly default status reports for so long as LED remains in default of the financial statement filing requirement.

The Audit Committee of the Company has reviewed the contents of this news release.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc. is a leading developer of LED-based visualization technologies for the medical industry. The Company is currently listed on the Toronto Stock Exchange (TSX-V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, visit [ www.ledmd.com ]. Through its wholly-owned subsidiary, LED Dental Inc., the company manufactures the VELscope® Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. VELscope® Vx devices are now used to conduct more screenings for oral cancer and other oral tissue abnormalities than any other adjunctive device. For more information, visit [ www.leddental.com ].

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.




Publication Contributing Sources